Nuvation Bio Quarterly Balance Sheet
NYSE: NUVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Nuvation Bio financial position
As of Jun 30, 2026, Nuvation Bio reported total assets of $744.5 million, up 15.0% from a year earlier against total liabilities of $490.6 million. Shareholders' equity stood at $253.9 million, or 34.1% of assets. The company held $258.6 million in cash and equivalents against $5.9 million of debt, a net cash position of $252.7 million.
The current ratio (current assets divided by current liabilities) was 8.37, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.02.
Summary generated from market data by MetaCap's automated system. Methodology
Nuvation Bio balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 258.60M | 125.39M | 164.09M | 98.90M | 247.97M | 47.98M | 35.72M | 30.04M | 34.28M | 34.51M | 42.65M | 24.39M |
| Short-Term Investments | 402.35M | 408.34M | 365.13M | 450.15M | 359.75M | 413.70M | 466.97M | 519.10M | 542.88M | 562.47M | 568.56M | 594.94M |
| Inventory | 19.90M | 15.84M | 11.41M | 5.71M | 552.00K | 14.00K | 0 | — | — | — | — | — |
| Total Current Assets | 726.43M | 591.53M | 571.52M | 577.53M | 623.21M | 475.57M | 526.25M | 564.99M | 587.17M | 608.05M | 616.43M | 625.35M |
| Property, Plant & Equipment | 715.00K | 535.00K | 564.00K | 560.00K | 615.00K | 562.00K | 586.00K | 719.00K | 751.00K | 686.00K | 717.00K | 764.00K |
| Intangible Assets | 10.29M | 10.76M | 11.21M | 11.68M | 12.14M | 4.41M | 4.62M | 2.78M | 2.93M | — | 0 | — |
| Total Assets | 744.50M | 610.24M | 594.82M | 601.56M | 647.23M | 492.49M | 540.63M | 571.58M | 594.80M | 613.13M | 621.48M | 630.87M |
| Accounts Payable | 12.09M | 22.43M | 9.48M | 15.36M | 22.42M | 10.54M | 6.35M | 12.38M | 5.21M | 2.44M | 2.21M | 2.37M |
| Short-Term Debt | 5.89M | 5.79M | 5.72M | 5.62M | 5.58M | 5.68M | 6.28M | 8.43M | 11.63M | — | 0 | — |
| Total Current Liabilities | 86.75M | 79.52M | 82.23M | 68.13M | 66.36M | 52.77M | 58.24M | 59.03M | 51.09M | 15.76M | 13.97M | 16.14M |
| Long-Term Debt | 0 | 47.33M | 47.21M | 47.09M | 46.97M | — | 0 | — | — | — | — | — |
| Total Liabilities | 490.64M | 290.68M | 289.11M | 275.68M | 274.32M | 73.03M | 76.84M | 68.86M | 62.66M | 19.08M | 16.36M | 19.28M |
| Shareholders' Equity | 253.86M | 319.56M | 305.72M | 325.88M | 372.91M | 419.46M | 463.79M | 502.71M | 257.19M | 594.04M | 605.12M | 611.59M |
| Retained Earnings | -1.17B | -1.11B | -1.12B | -1.08B | -1.02B | -963.98M | -910.74M | -861.30M | -820.09M | -357.60M | -342.80M | -329.02M |
| Total Debt | 5.89M | 53.12M | 52.93M | 52.71M | 52.56M | 5.68M | 6.28M | 8.43M | 11.63M | — | 0 | — |
| Net Cash (Debt) | 655.06M | 480.61M | 476.28M | 496.34M | 555.16M | 455.99M | 496.41M | 540.71M | 565.53M | 596.98M | 611.21M | 619.34M |
| Shares Outstanding | 346.50M | 346.50M | 346.50M | 337.84M | 337.84M | 337.84M | 337.84M | 336.25M | 248.62M | 219.08M | 219.05M | 218.94M |
This table shows 12 quarterly periods of Nuvation Bio's balance sheet, from Q2 2026 back to Q3 2023, across 17 line items including cash & equivalents, short-term investments, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow NUVB's reporting calendar. What is a balance sheet?